Evidence map›Paper›PMID 28754906›Full record

ArticleScientific reports2017

KRAS Activation and over-expression of SIRT1/BCL6 Contributes to the Pathogenesis of Endometriosis and Progesterone Resistance.

Jung-Yoon Yoo, Tae Hoon Kim, Asgerally T Fazleabas, Wilder A Palomino, Soo Hyun Ahn, Chandrakant Tayade, David P Schammel, Steven L Young, Jae-Wook Jeong, Bruce A Lessey

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
13.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04107129 completednot on this mapstarted 2020, after this paper: background citation

Predicting Endometrial Receptivity for Optimal Reproductive Management (PERFORM)

TypeobservationalSponsorStanford UniversityRan2020 to 2024Enrolled76ConditionsInfertility, Female, EndometriosisArmsEndometrial Biopsy, Euploid embryo transfer, Blood sample
NCT04184323 phase2withdrawnnot on this mapstarted 2022, after this paper: background citation

SIRT1-1 Antagonist Therapy Before Embryo Transfer to Improve Endometrial Receptivity and Life Pregnancy Rates

TypeinterventionalSponsorWake Forest University Health SciencesRan2022 to 2023Enrolled0ConditionsEndometriosis, Uterine Diseases, Endometrial Diseases, Infertility UnexplainedArmsEX-527 (Selisistat), Placebo
3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 131 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Research Progress of Histone Deacetylase and Its Inhibitors in Endometriosis.Reproductive sciences (Thousand Oaks, Calif.) · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Observational
  12. Review
  13. Nanoceria as a non-steroidal anti-inflammatory drug for endometriosis theranostics.Journal of controlled release : official journal of the Controlled Release Society · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Association betweenCurrent issues in molecular biology · 2024
    Article
  19. Review
  20. Transgenic mice applications in the study of endometriosis pathogenesis.Frontiers in cell and developmental biology · 2024
    Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Jung-Yoon YooObstetrics, Gynecology & Reproductive Biology, Michigan State University, Grand Rapids, MI, 49503, USA.
Tae Hoon KimObstetrics, Gynecology & Reproductive Biology, Michigan State University, Grand Rapids, MI, 49503, USA.
Asgerally T FazleabasObstetrics, Gynecology & Reproductive Biology, Michigan State University, Grand Rapids, MI, 49503, USA.
Wilder A PalominoInstitute for Maternal and Child Research, Faculty of Medicine, University of Chile, Santiago, Chile.
Soo Hyun AhnDepartment of Biomedical and Molecular Sciences, Queens University, Kingston, ON K7L 3N6, Canada.
Chandrakant TayadeDepartment of Biomedical and Molecular Sciences, Queens University, Kingston, ON K7L 3N6, Canada.
David P SchammelPathology Associates, Greenville Hospital System, Greenville, SC, 29605, USA.
Steven L YoungObstetrics and Gynecology, University of North Carolina, Chapel Hill, NC, 27514, USA.
Jae-Wook JeongObstetrics, Gynecology & Reproductive Biology, Michigan State University, Grand Rapids, MI, 49503, USA. jeongj@msu.edu.
Bruce A LesseyObstetrics and Gynecology, Greenville Health System, Greenville, SC, 29605, USA. blessey@ghs.org.
Michigan State University · USPrisma Health · USQueen's University · CASpectrum Health · USUniversity of Chile · CLUniversity of North Carolina at Chapel Hill · US

Funding

Progesterone Action in the Endometrium of Women with EndometriosisR01HD067721 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI YOUNG, STEVEN L · 2011 to 2015
$3.1M
Role of microRNA in the Pathophysiology of EndometriosisR01HD083273 · NICHD · MICHIGAN STATE UNIVERSITY · PI FAZLEABAS, ASGERALLY T. · 2016 to 2020
$1.8M
Risk factors for early pregnancy lossR01HD084478 · NICHD · MICHIGAN STATE UNIVERSITY · PI JEONG, JAE-WOOK · 2016 to 2020
$1.6M
NICHD NIH HHS R01 HD067721NICHD NIH HHS R01 HD083273NICHD NIH HHS R01 HD084478
6 · The paper itself

Abstract

Endometriosis is an inflammatory condition that is associated with progesterone resistance and cell proliferation, resulting in pain, infertility and pregnancy loss. We previously demonstrated phosphorylation of STAT3 in eutopic endometrium of infertile women with this disorder leading to over-expression of the oncogene BCL6 and stabilization of hypoxia-induced factor 1 alpha (HIF-1α). Here we report coordinated activation of KRAS and over-expression of Sirtuin 1 (SIRT1), a histone deacetylase and gene silencer, in the eutopic endometrium from women with endometriosis throughout the menstrual cycle. The mice with conditional activation of KRAS in the PGR positive cells reveal an increase of SIRT1 expression in the endometrium compared to control mice. The expression of progesterone receptor target genes including the Indian Hedgehog pathway genes are significantly down-regulated in the mutant mice. SIRT1 co-localizes with BCL6 in the nuclei of affected individuals and both proteins bind to and suppress the promoter of GLI1, a critical mediator of progesterone action in the Indian Hedgehog pathway, by ChIP analysis. In eutopic endometrium, GLI1 expression is reduced in women with endometriosis. Together, these data suggest that KRAS, SIRT1 and BCL6 are coordinately over-expressed in eutopic endometrium of women with endometriosis and likely participate in the pathogenesis of endometriosis.

Indexed as

AdolescentAdultAnimalsCytokinesDisease Models, AnimalDisease ProgressionEndometriosisEndometriumFemaleGene Expression RegulationHumansInflammationMiceMiddle AgedPapioProto-Oncogene Proteins c-bcl-6BCL6 protein, humanCytokinesKRAS protein, humanProto-Oncogene Proteins c-bcl-6Proto-Oncogene Proteins p21(ras)SIRT1 protein, humanSirtuin 1Zinc Finger Protein GLI1

Identifiers

PMID28754906
PMCPMC5533722
OpenAlexW2737330582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.